Literature DB >> 3871792

T cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases.

M A Bach, C Martin, P Cesaro, J F Eizenbaum, J D Degos.   

Abstract

Twenty-four untreated MS patients with exacerbating-remitting disease were longitudinally studied for T-cell subset distribution within peripheral blood, using monoclonal antibodies OKT3, OKT4 and OKT8. A decreased percentage of OKT8 reactive cells, with a correlative increase of the OKT4/OKT8 ratio, was detected in relapsing MS patients, in most cases within 2 weeks before and 1 week after the onset of relapse. Longitudinal analysis of individual fluctuations allowed to detect during relapse an increase of OKT4/OKT8 ratio over the value recorded during remission in 78% of MS patients. Only 50% of patients however exhibited an OKT4/OKT8 ratio exceeding the 5% confidence upper limit of healthy control values. Relapse was more often associated with T-cell subset abnormalities in patients who suffered several attacks during the period of study. MS patients in remission, when considered as a group did not show significant abnormalities of the T-cell subset balance, although some individuals did present with wider T-cell subset fluctuations than healthy controls.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871792

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Serial studies of evoked potentials and circulating lymphocyte subsets for multiple sclerosis: attempts to monitor progress.

Authors:  H M Chapel; M Small; S Gregory; W B Matthews
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

Review 2.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

Review 4.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

5.  The behaviour of OKT3-, OKT4- and OKT8-positive cells during phases of elevated spontaneous chemiluminescence activity (CL-A) in multiple sclerosis patients. A serial study.

Authors:  K P Hammann; R Röder; H C Hopf
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

6.  Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity.

Authors:  M Eoli; M Ferrarini; A Dufour; S Heltaj; L Bevilacqua; G Comi; V Cosi; G Filippini; V Martinelli; C Milanese
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

7.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

8.  T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?

Authors:  A Henneberg; E G Fischer; H H Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

Review 9.  Multiple sclerosis: neuroimmunologic puzzle.

Authors:  B P Barna
Journal:  Clin Lab Med       Date:  1986-03       Impact factor: 1.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.